Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
IN8bio, Inc. (Nasdaq: INAB) announced that its Compensation Committee granted a new employee nonqualified stock options to purchase 60,000 shares of common stock as an inducement to join the company. The options vest over four years with 25% vesting on the first anniversary and the remainder in equal monthly installments thereafter.
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing gamma-delta T cell therapies, announced that CEO William Ho will present at the Sidoti Small-Cap Virtual Conference on September 24, 2026. The presentation will cover the company's differentiated γδ T cell platform and pipeline, including lead program INB-619 and clinical-stage oncology programs.
IN8bio (NASDAQ:INAB) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.37) by 32.43 percent. This is a 79.84 percent increase over losses of $(1.24) per share from the same
Gainers Tenet Healthcare (NYSE:THC) shares rose 14.1% to $227.06 during Thursday's after-market session. The company's market cap stands at $17.1 billion. As per the news, the Q2 earnings report came out today.